This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (25)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Obesity  • Women's Health  • Women's Health, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Francisco Álvarez-Blasco, MD; José I. Botella-Carretero, MD, PhD; José L. San Millán, PhD; Héctor F. Escobar-Morreale, MD, PhD

Arch Intern Med. 2006;166:2081-2086.

Background  Surprisingly, the prevalence of polycystic ovary syndrome (PCOS) in otherwise unselected overweight or obese women is unknown, despite obesity being frequent in patients with PCOS. We conducted the present study to obtain an unbiased estimate of the prevalence of PCOS in unselected overweight and obese premenopausal women from Spain.

Methods  All premenopausal women reporting to the Department of Endocrinology, Hospital Universitario Ramón y Cajal, for dietary treatment of overweight or obesity from May 2002 to December 2005 were prospectively recruited. Women referred for any other reason were automatically excluded to avoid selection bias. Diagnosis of PCOS relied on the presence of clinical and/or biochemical hyperandrogenism, oligo-ovulation, and exclusion of secondary causes. Anthropometric measurements, hirsutism scores, and androgen, gonadotropin, metabolic, and lipid profiles were obtained.

Results  Of a total of 113 consecutive women recruited, 32 (28.3%) were diagnosed as having PCOS (95% confidence interval, 20.0%-36.6%). The prevalence of PCOS was not different when considering the degree of obesity. Another 3 women presented with hyperandrogenemia without oligo-ovulation, 2 had idiopathic hirsutism, 2 had chronic oligomenorrhea without clinical or biochemical hyperandrogenism, and 2 had oligomenorrhea with hyperprolactinemia, precluding the diagnosis of PCOS. The remaining 72 women (63.7%) had no evidence of hyperandrogenism or reproductive abnormalities.

Conclusions  Our results demonstrate a 28.3% prevalence of PCOS in overweight and obese women from Spain, which is markedly increased compared with the 5.5% prevalence of PCOS in lean women of our country. Therefore, PCOS must be routinely ruled out in overweight and obese premenopausal women seeking advice for weight loss.

Author Affiliations: Departments of Endocrinology (Drs Álvarez-Blasco, Botella-Carretero, and Escobar-Morreale) and Molecular Genetics (Dr San Millán), Hospital Universitario Ramón y Cajal, Madrid, Spain.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Unique Rodent Model of Cardiometabolic Risk Associated with the Metabolic Syndrome and Polycystic Ovary Syndrome
Shi et al.
Endocrinology 2009;150:4425-4436.
ABSTRACT | FULL TEXT  

Effects of an antiandrogenic oral contraceptive pill compared with metformin on blood coagulation tests and endothelial function in women with the polycystic ovary syndrome: influence of obesity and smoking
Luque-Ramirez et al.
Eur J Endocrinol 2009;160:469-480.
ABSTRACT | FULL TEXT  

Gene expression microarray profiles of cumulus cells in lean and overweight-obese polycystic ovary syndrome patients
Kenigsberg et al.
Mol Hum Reprod 2009;15:89-103.
ABSTRACT | FULL TEXT  

The Metabolic Syndrome
Cornier et al.
Endocr. Rev. 2008;29:777-822.
ABSTRACT | FULL TEXT  

Consensus on infertility treatment related to polycystic ovary syndrome
The Thessaloniki ESHRE/ASRM-Sponsored PCOS Consens
Hum Reprod 2008;23:462-477.
ABSTRACT | FULL TEXT  

Polycystic Ovary Syndrome (PCOS) and Other Androgen Excess-Related Conditions: Can Changes in Dietary Intake Make a Difference?
Liepa et al.
Nutr Clin Pract 2008;23:63-71.
ABSTRACT | FULL TEXT  

Impact of Obesity on the Risk for Polycystic Ovary Syndrome
Yildiz et al.
J. Clin. Endocrinol. Metab. 2008;93:162-168.
ABSTRACT | FULL TEXT  

Androgen excess is associated with the increased carotid intima-media thickness observed in young women with polycystic ovary syndrome
Luque-Ramirez et al.
Hum Reprod 2007;22:3197-3203.
ABSTRACT | FULL TEXT  

Increased Body Iron Stores of Obese Women With Polycystic Ovary Syndrome Are a Consequence of Insulin Resistance and Hyperinsulinism and Are Not a Result of Reduced Menstrual Losses
Luque-Ramirez et al.
Diabetes Care 2007;30:2309-2313.
ABSTRACT | FULL TEXT  

Comparison of Ethinyl-Estradiol Plus Cyproterone Acetate Versus Metformin Effects on Classic Metabolic Cardiovascular Risk Factors in Women with the Polycystic Ovary Syndrome
Luque-Ramirez et al.
J. Clin. Endocrinol. Metab. 2007;92:2453-2461.
ABSTRACT | FULL TEXT  

Differential Gene Expression Profile in Omental Adipose Tissue in Women with Polycystic Ovary Syndrome
Corton et al.
J. Clin. Endocrinol. Metab. 2007;92:328-337.
ABSTRACT | FULL TEXT